3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycystic Ovary Syndrome
4
Obesity
4
Breast Neoplasms
4
Ovarian Diseases
2
Ovarian Cysts
2
Motor Activity
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Feeding Behavior
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Angina, Unstable
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
10
Peripheral Blood Stem Cell Transplantation
9
Cyclosporine
7
Mycophenolic Acid
6
Filgrastim
6
Antilymphocyte Serum
6
Whole-Body Irradiation
5
Busulfan
5
Radiotherapy
4
Psychiatric Rehabilitation
4
Cytarabine
4
Methylprednisolone
3
Methotrexate
3
Melphalan
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
thymoglobulin
2
Therapeutics
2
Tacrolimus
2
Polymerase Chain Reaction
2
Ondansetron
2
Mesna
2
Flow Cytometry
2
Dexamethasone
2
Calcium Dobesilate
2
Analgesia
2
sargramostim
1
plerixafor
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myeloproliferative Disorders
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled